Lars Hendrik Müschen

549 total citations
13 papers, 307 citations indexed

About

Lars Hendrik Müschen is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Lars Hendrik Müschen has authored 13 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Neurology and 5 papers in Molecular Biology. Recurrent topics in Lars Hendrik Müschen's work include Neurogenetic and Muscular Disorders Research (7 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and RNA modifications and cancer (3 papers). Lars Hendrik Müschen is often cited by papers focused on Neurogenetic and Muscular Disorders Research (7 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and RNA modifications and cancer (3 papers). Lars Hendrik Müschen collaborates with scholars based in Germany. Lars Hendrik Müschen's co-authors include Susanne Petri, Olivia Schreiber‐Katz, Alma Osmanovic, Lejla Paracka, Thomas Skripuletz, Martin Stangel, Martin W. Hümmert, Stefan Gingele, Lena Bönig and Sascha Alvermann and has published in prestigious journals such as Clinical Neurophysiology, Cells and Journal of Neurology.

In The Last Decade

Lars Hendrik Müschen

11 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Hendrik Müschen Germany 9 132 104 79 77 54 13 307
Vaidya Govindarajan United States 10 53 0.4× 40 0.4× 34 0.4× 87 1.1× 33 0.6× 37 280
Omaira Molina Venezuela 11 130 1.0× 25 0.2× 124 1.6× 45 0.6× 10 0.2× 18 287
Seyed Mohammad Baghbanian Iran 9 88 0.7× 21 0.2× 132 1.7× 32 0.4× 32 0.6× 43 236
Gholamreza Zamani Iran 11 36 0.3× 99 1.0× 30 0.4× 129 1.7× 11 0.2× 50 387
Maryam Poursadeghfard Iran 9 59 0.4× 22 0.2× 98 1.2× 29 0.4× 14 0.3× 48 254
Zhaoxia Liu China 10 62 0.5× 68 0.7× 11 0.1× 45 0.6× 21 0.4× 34 308
Tim Lotze United States 6 182 1.4× 13 0.1× 199 2.5× 43 0.6× 24 0.4× 11 305
Konstantin Fritz Jendretzky Germany 10 87 0.7× 38 0.4× 117 1.5× 62 0.8× 15 0.3× 24 231
Reza Vosoughi Canada 9 107 0.8× 14 0.1× 194 2.5× 52 0.7× 62 1.1× 22 354
C. Abasq France 7 22 0.2× 114 1.1× 174 2.2× 18 0.2× 36 0.7× 29 358

Countries citing papers authored by Lars Hendrik Müschen

Since Specialization
Citations

This map shows the geographic impact of Lars Hendrik Müschen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Hendrik Müschen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Hendrik Müschen more than expected).

Fields of papers citing papers by Lars Hendrik Müschen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Hendrik Müschen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Hendrik Müschen. The network helps show where Lars Hendrik Müschen may publish in the future.

Co-authorship network of co-authors of Lars Hendrik Müschen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Hendrik Müschen. A scholar is included among the top collaborators of Lars Hendrik Müschen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Hendrik Müschen. Lars Hendrik Müschen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Körner, Sonja, Lars Hendrik Müschen, Tabea Seeliger, et al.. (2023). Cranial nerve involvement in patients with immune-mediated neuropathy: An observational blink reflex study. Clinical Neurophysiology. 149. 168–175.
2.
Müschen, Lars Hendrik, et al.. (2023). Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis. Cells. 12(5). 736–736. 33 indexed citations
3.
Müschen, Lars Hendrik, Susanne Petri, & Sonja Körner. (2022). Moderne Diagnosestellung der Amyotrophen Lateralsklerose – ein Update der Diagnosekriterien. Klinische Neurophysiologie. 53(1). 48–58.
4.
Müschen, Lars Hendrik, Alma Osmanovic, Konstantin Fritz Jendretzky, et al.. (2021). Cerebrospinal Fluid Parameters in Antisense Oligonucleotide-Treated Adult 5q-Spinal Muscular Atrophy Patients. Brain Sciences. 11(3). 296–296. 16 indexed citations
5.
Osmanovic, Alma, Claudia D. Wurster, Benjamin Stolte, et al.. (2021). Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy. Therapeutic Advances in Neurological Disorders. 14. 1280220470–1280220470. 14 indexed citations
6.
Härtung, Thomas, Mathias Rhein, Norman Kalmbach, et al.. (2021). Methylation and Expression of Mutant FUS in Motor Neurons Differentiated From Induced Pluripotent Stem Cells From ALS Patients. Frontiers in Cell and Developmental Biology. 9. 774751–774751. 8 indexed citations
7.
Osmanovic, Alma, Lars Hendrik Müschen, Lejla Paracka, et al.. (2020). Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy. Journal of Neurology. 267(8). 2398–2407. 32 indexed citations
8.
Osmanovic, Alma, et al.. (2020). Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany. Orphanet Journal of Rare Diseases. 15(1). 149–149. 21 indexed citations
9.
Müschen, Lars Hendrik, Mathias Rhein, Kerstin Schwabe, et al.. (2019). Alcohol Withdrawal and Proopiomelanocortin Neuropeptides in an Animal Model of Alcohol Dependence. Neuropsychobiology. 78(3). 118–127. 4 indexed citations
10.
Gingele, Stefan, Martin W. Hümmert, Sascha Alvermann, et al.. (2019). Routine Cerebrospinal Fluid Cytology Reveals Unique Inclusions in Macrophages During Treatment With Nusinersen. Frontiers in Neurology. 10. 735–735. 16 indexed citations
11.
Rhein, Mathias, Thomas Hillemacher, Ralf Lichtinghagen, et al.. (2019). DNA Methylation of the Leptin Gene Promoter is Altered by Chronic Alcohol Exposure in an Animal Model for Alcohol Dependence. European Addiction Research. 25(2). 49–55. 5 indexed citations
12.
Gingele, Stefan, Franz Felix Konen, Martin W. Hümmert, et al.. (2018). Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients. Cells. 8(1). 12–12. 109 indexed citations
13.
Klietz, Martin, Lars Hendrik Müschen, Lejla Paracka, et al.. (2018). Impaired Quality of Life and Need for Palliative Care in a German Cohort of Advanced Parkinson’s Disease Patients. Frontiers in Neurology. 9. 120–120. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vaidya Govindarajan Breakdown of academic impact, for papers by Omaira Molina Breakdown of academic impact, for papers by Seyed Mohammad Baghbanian Breakdown of academic impact, for papers by Gholamreza Zamani Breakdown of academic impact, for papers by Maryam Poursadeghfard Breakdown of academic impact, for papers by Zhaoxia Liu Breakdown of academic impact, for papers by Tim Lotze Breakdown of academic impact, for papers by Konstantin Fritz Jendretzky Breakdown of academic impact, for papers by Reza Vosoughi Breakdown of academic impact, for papers by C. Abasq
Rankless by CCL
2026